|
|
Home > Healthcare > Pharmaceutical > Drug Products
Pharmaceutical and healthcare market in Poland 2009
|
| Published Date:
June 2009
Published By:
PMR Ltd.
Order Code:
R320-164
|
|
|
|
The report comprises the complete economic analysis of pharmaceutical sector in Poland as well as recent data on healthcare sector in the region and contains forecast projections for 2009-2011.
The value data are presented for the total market, pharmacy and hospital segment, Rx, foreign and domestic drugs, generic and innovative medicines, and main ATC categories together with forecasts.
The report offers insights into ongoing trends, taking a closer look at areas of growth and decline. Factors that influence the market, from epidemiology to consumer behaviour, are studied and presented for your thorough understanding of the market. Economic data, such as employment and cost-revenue analysis of the pharmaceutical sector, are also covered.
Our analysis also takes into account the latest changes in reimbursement and legislation (latest and expected). The impact of global financial crisis has also been analysed and taken into consideration in the forecasts provided for the size of the Polish pharmaceutical and healthcare market by the PMR team of pharmaceutical analysts and economists.
If you are looking for:
- detailed information on legal environment together with most important changes in the “minor” and “major” amendments to the Pharmaceutical Act, analysis of changes is Act on Healthcare Services Financed from Public Funds
- analysis of latest novelisations of reimbursement lists and their impact on the market
- profiles of largest players active on pharma market
- strategic key data
- data needed for market entry
- description of epidemiologic and demographic trends
- economic trends analysis
- consumer behaviour in Poland analysis
|
Similar Products
• Pharmaceutical Industry in the United States - Porter’s Five Forces Strategy Analysis
Published Nov 2009 by Aruvian's R'search
• Pharmaceuticals Industry Report
Published Nov 2009 by Plimsoll Publishing Ltd.
• Commercial Insight: Antidiabetics in Australia - Reimbursement status shapes novel classes
Published Oct 2009 by Datamonitor
• Prescription Drug Wholesaling in the US - Industry Risk Rating Report
Published Oct 2009 by IBISWorld
• Antidepressants Market Forecast
Published Oct 2009 by Datamonitor
• Snapshots Bulgaria Pharmaceuticals 2009
Published Oct 2009 by Snapdata International Group
• Snapshots France Pharmaceuticals 2009
Published Oct 2009 by Snapdata International Group
• Snapshots Australia Pharmaceuticals 2009
Published Oct 2009 by Snapdata International Group
• Commercial Insight: Anticonvulsants - Non-epilepsy label expansions provide blockbuster potential
Published Oct 2009 by Datamonitor
|
|
|
|
0 items
